The Company

We are an American company with a worldwide vision. From our headquarters in San Diego, California, American Radiosurgery has provided surgeons and patients around the world with revolutionary neurosurgical equipment tools. We are the first company in the United States to produce a device utilizing rotating gamma technology for the non-invasive treatment of brain tumors.

Our mission is to utilize the latest technology and the most innovative design to create superior cancer treatment modalities. We strive to provide cancer treating physicians with outstanding products that augment their clinical expertise and maximize patient outcomes.

Would we choose our technology to treat our own cancer? The confidence we have in the excellence of every American Radiosurgery® product is our greatest asset.

History

We believe in choices. Since our inception in 1999, American Radiosurgery has enabled hospitals and medical centers around the world to establish top-rated neurosurgery programs with affordable, state of the art machinery.

Prior to 1997, there was only one high-precision, dedicated system for intracranial radiosurgery in existence — the Gamma Knife™, manufactured by the Swedish company Elekta AB®. Introduced in 1968, this technology remains essentially unchanged.

In 1997, a new dedicated radiosurgery system design was patented, manufactured and introduced. After further refinement to the mechanization and a change in corporate ownership, this device was reintroduced in 2000 by American Radiosurgery as the Rotating Gamma System® Vertex360™.

American Radiosurgery also produces a soon to be FDA-approved revolutionary neuroradiosurgical device. This new device will exceed all current levels of treatment capabilities in the field of neurosurgery. These tools give neurosurgeons the power to target tumors not previously reachable with the older, outdated modalities.

The company plans to introduce a high performance, low-cost linear accelerator to address the need for such a device in the radiation oncology field in late 2008. This unit will incorporate dramatic new technology that can be delivered to the hands of a treating physician on a cost-effective basis.